Who
David Scott Tomsche
Director
Company insider
Files Form 4 as: Director, ImmuCell.
In numbers
- Trades disclosed
- 125
- Buys
- 29
- Sells
- 0
- Bought
- $424K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 11 Sep 2007
- Last trade
- 15 Apr 2026
- Last filed
- 16 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,933 at $0.00 | filing |
| 15 Apr 2026filed 16 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —11,933 at $0.00 | filing |
| 25 Nov 2025filed 28 Nov 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $7,7731,633 at $4.76 | filing |
| 25 Nov 2025filed 28 Nov 2025 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Bought | $7,7891,633 at $4.77 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 16 Apr 2025filed 14 Apr 2026 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 20 Sep 2024filed 24 Sep 2024 | ICCC ImmuCelloption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $36K10,000 at $3.60 | filing |
| 28 Aug 2024filed 30 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $7,7602,186 at $3.55 | filing |
| 23 Aug 2024filed 26 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $21K6,005 at $3.55 | filing |
| 22 Aug 2024filed 22 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $36K10,000 at $3.55 | filing |
| 19 Aug 2024filed 19 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $12K3,172 at $3.67 | filing |
| 16 Aug 2024filed 19 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $18K4,811 at $3.72 | filing |
| 15 Aug 2024filed 19 Aug 2024 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $7,2012,017 at $3.57 | filing |
| 6 Sep 2023filed 6 Sep 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $15K3,100 at $4.75 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $39171 at $5.50 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $1,700309 at $5.50 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $4,546831 at $5.47 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $553100 at $5.53 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $38269 at $5.53 | filing |
| 14 Mar 2023filed 15 Mar 2023 | ICCC ImmuCellDiagnostics & Labs | SEC FORM 4 Code D | $17131 at $5.53 | filing |
News
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales ResultsICCC · manilatimes.net · 12 Oct 2026
0 headlines in the last 90 days name David Scott Tomsche; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.